CARLEY CAMPTON: Open Payments
NPI 1457844482 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 59 payments from 10 companies in 2025. Trend: 2023 $77 · 2024 $312 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 40 | $281 |
| Novo Nordisk Inc | 5 | $94 |
| Amgen Inc. | 5 | $94 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Recor Medical Inc | 1 | $25 |
| CVRx, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Corium, LLC | 1 | $9 |
Products named: LEQVIO, REPATHA, Wegovy, AMVUTTRA, VERQUVO, EVKEEZA, Paradise Ultrasound Renal Denervation System, Barostim Neo System.
Industry payments across AZ — which companies pay providers there.
